Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma

Haldar, P

Haldar, P (reprint author), Glenfield Hosp, Resp Biomed Res Unit, Leicester LE3 9QP, Leics, England.

BIOLOGICS-TARGETS & THERAPY, 2017; 11 ( ): 81

Abstract

Mepolizumab (Nucala (R)) is an effective and specific anti-eosinophil molecular therapy that has recently been approved as add-on therapy for the mana......

Full Text Link